In this presentation, Dr. Gary Houchard, PharmD, a specialized palliative medicine pharmacist, delivers an in-depth exploration of buprenorphine’s potential as an analgesic. Dr. Houchard compares buprenorphine to commonly prescribed full… […]
Keyword: buprenorphine
Prescribing Buprenorphine for Chronic Pain | September 10, 2024
In this presentation, Sarah Spencer, DO, discusses buprenorphine in relation to chronic pain. She covers how to identify patients with chronic pain that could benefit from switching from chronic full… […]
Read More… from Prescribing Buprenorphine for Chronic Pain | September 10, 2024
Management of SUDs: Clinical Application & Key Pearls | July 23, 2024
In this presentation, Dr. Wei Sum Li, MD, provides an extensive, provider-focused overview of the management of substance use disorders as a chronic disease in the primary care setting. Dr.… […]
Read More… from Management of SUDs: Clinical Application & Key Pearls | July 23, 2024
Acute Withdrawal Considerations | June 25, 2024
In this presentation, Dr. Kathryn Hawk, MD, MHS & Dr. Ryan Buckley, MD, MPH, review management of common withdrawal syndromes (alcohol use, opioid use, benzodiazepine use, methamphetamine and cocaine use),… […]
Read More… from Acute Withdrawal Considerations | June 25, 2024
Buprenorphine Long-Acting Injectables | April 16, 2024
In this presentation, LCDR Draude, PharmD, describes the available buprenorphine Long-Acting Injectable (LAI) agents. LCDR Draude compares and contrasts the LAIs, including dosing and clinical considerations, and discusses the use… […]
Read More… from Buprenorphine Long-Acting Injectables | April 16, 2024
Buprenorphine Macrodosing | January 16, 2024
In this presentation. Dr. Jessica Gregg and Dr. James Gasper, provide an overview of ‘macro’ or ‘high dose’ induction of buprenorphine, including the theory behind the concept and the limited… […]
Read More… from Buprenorphine Macrodosing | January 16, 2024
Implementation of an OUD Treatment Program in the ED | September 26, 2023
In this presentation, Dr. Kathryn Hawk, attending physician in the Yale New Haven Hospital Emergency Department and an Associate Professor in the Department of Emergency Medicine, the Yale School of… […]
Read More… from Implementation of an OUD Treatment Program in the ED | September 26, 2023
Low Dose Buprenorphine Induction | August 3 2023
In this presentation, Dr. Jonathan Robbins, MD, defines buprenorphine microdosing and several protocols for microinduction. Additionally, case studies from both inpatient and outpatient settings are reviewed as well as guidelines… […]
Read More… from Low Dose Buprenorphine Induction | August 3 2023
Buprenorphine Microdosing Induction | August 2, 2023
In this presentation, Dr. Jasen Christensen, MD, defines buprenorphine microdosing and shares prescribing pearls. Dr Christensen explains the need for alternative induction methods, describes the reasoning behind buprenorphine microdosing induction,… […]
Read More… from Buprenorphine Microdosing Induction | August 2, 2023
Management of SUDs: Clinical Application & Key Pearls | May 25, 2023
In this presentation, Dr. Wei Sum Li, MD, provides an extensive, provider-focused overview of the management of substance use disorders as a chronic disease in the primary care setting. Dr.… […]
Read More… from Management of SUDs: Clinical Application & Key Pearls | May 25, 2023